TGA Approval

SYNAGIS palivizumab (rmc) 100 mg / 1 mL solution for injection vial (231139)

ARTG ID

231139

ARTG Name

SYNAGIS palivizumab (rmc) 100 mg / 1 mL solution for injection vial

Sponsor

AstraZeneca Pty Ltd

ARTG Date

September 24, 2015

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

ASTRAZENECA PTY LTD

https://medical-cdn.nocode.com/drug_tga/936d77d5227fba45c45dafaeb2eed1d0.pdf

https://medical-cdn.nocode.com/drug_tga/8c895aad32fe407c41d3c2b6106f1fde.pdf

Ingredient Name

Palivizumab

Empowering clinical research with data-driven insights and AI-powered tools.

SYNAGIS palivizumab (rmc) 100 mg / 1 mL solution for injection vial (231139) - TGA 批准文号 | MedPath